510(k) Vs CE Mark

by | Oct 23, 2019 | 510k, EU, EU MDR, FDA, Medical Devices, Quality Systems, Regulatory, Requirements

A 510(k) is the most utilized regulatory pathway to market a medical device in the US. For a device of the same level of risks, a CE Mark is required to market a medical device in the European Economic area.

In order to obtain a CE mark, a manufacturer must demonstrate that they comply with the EU MDD and beginning May 2020 companies will have to comply with the EU MDR.

When a manufacturer submits the pre-market notification 510(k) application, the manufacturer needs to ensure that the design history file (DHF) is ready to be included in the application. And while the application is in the process of being reviewed, the manufacturer may get all the design transfer and manufacturing activities tied up and generate the Device Master Record (DMR). 1

With the CE mark application, the company must have its DMR and its manufacturing activities validated before the audit. The technical file that is required to be created for the product must contain all of its risk documentation in accordance with ISO 14971, which includes the risk analysis, risk management plan, risk mitigation measures, external testing certificates and clinical evaluation reports that demonstrate the clinical safety and effectiveness of the product, either in the form of clinical trials or literature review.1

Another major difference is the Quality Management System requirements. With the CE marking, the quality system is audited as part of the process before the notified body can grant the CE mark. Conversely, to get your device cleared through the 510(k) path, the QMS has to be compliant to 21CFR820 and is audited via unannounced inspections by the FDA. The EU MDD and the MDR have annexes that contain the QMS requirements; however since there are multiple directives and each directive indicates multiple ways for a device manufacturer to conform to the QMS requirements, it is more common for companies to comply with ISO 13485.1

EMMA International can make it easy for you to comply with the US and EU regulations. Give us a call at 248-987-4497 or email us at info@emmainternational.com.


1Starfish Medical 5 Similarities and Differences between Medical Device 510(k) and CE Marking Pt. 2 retrieved on 10/17/2019 from https://starfishmedical.com/blog/510k-ce-marking-pt-2/

 

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

FDA Adverse Event Reporting 

FDA Adverse Event Reporting 

When reporting an Adverse Event to the Food and Drug Administration (FDA) the best method is to utilize the FDA Adverse Event Reporting System (FAERS). FAERS is a database that contains adverse event reports, product quality complaints that led to an adverse event, and medication error reports1. All FAERS reports are easily accessible to the public. 
De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.

Ready to learn more about working with us?

Pin It on Pinterest

Share This